Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas

被引：0
|
作者：
Alexander M. Spence
Richard A. Peterson
Jeffrey D. Scharnhorst
Daniel L. Silbergeld
Robert C. Rostomily
机构：
[1] University of Washington,Department of Neurology, 356465
[2] University of Washington School of Medicine,Departments of Neurology and Neurological Surgery
来源：
Journal of Neuro-Oncology | 2004年 / 70卷
关键词：
anaplastic astrocytoma; glioblastoma multiforme; phase II; Tamoxifen; Temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose and background: The aim of this study was to assess the frequency of response and toxicity in adults with recurrent anaplastic astrocytoma (AA) or glioblastoma multiforme (GM) treated with concurrent continuous TMZ and TMX.
引用
收藏
页码：91 / 95
页数：4
相关论文
共 50 条
  • [21] Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG).
    Lin, Xuling
    Kaley, Thomas Joseph
    Pentsova, Elena
    DeAngelis, Lisa Marie
    Daras, Mariza
    Gavrilovic, Igor T.
    Mellinghoff, Ingo K.
    McKeown, Andrew
    Manne, Malbora
    Hansen, Jessica
    Bavisotto, Linda M.
    Gorman, Greg
    Lamson, Michael
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV)
    Khasraw, Mustafa
    Abrey, Lauren E.
    Lassman, Andrew B.
    Hormigo, Adilia
    Nolan, Craig
    Gavrilovic, Igor T.
    Mellinghoff, Ingo K.
    Reiner, Anne S.
    DeAngelis, Lisa
    Omuro, Antonio M.
    NEURO-ONCOLOGY, 2010, 12 : 72 - 72
  • [23] PHASE-II STUDY OF FOTEMUSTINE IN RECURRENT SUPRATENTORIAL MALIGNANT GLIOMAS
    FRENAY, M
    GIROUX, B
    KHOURY, S
    DERLON, JM
    NAMER, M
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 852 - 856
  • [24] Phase II study of antiangiogenic (metronomic) chemotherapy for recurrent malignant gliomas
    Kesari, S.
    Schiff, D.
    Doherty, L.
    Gigas, D. C.
    Batchelor, T. T.
    Muzikansky, A.
    O'Neill, A.
    Drappatz, J.
    Chen-Plotkin, A.
    Ramakrishna, N.
    Weiss, S.
    Levy, B.
    Bradshaw, J.
    Black, P. M.
    Folkman, J.
    Kieran, M.
    Wen, P. Y.
    NEURO-ONCOLOGY, 2006, 8 (04) : 444 - 445
  • [25] Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
    Kesari, Santosh
    Schiff, David
    Doherty, Lisa
    Gigas, Debra C.
    Batchelor, Tracy T.
    Muzikansky, Alona
    O'Neill, Alison
    Drappatz, Jan
    Chen-Plotkin, Alice S.
    Ramakrishna, Naren
    Weiss, Stephanie E.
    Levy, Brenda
    Bradshaw, Joanna
    Kracher, Jean
    Laforme, Andrea
    Black, Peter McL.
    Folkman, Judah
    Kieran, Mark
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2007, 9 (03) : 354 - 363
  • [26] Phase II study of bevacizumab plus erlotinib for recurrent malignant gliomas
    Sathornsumetee, S.
    Desjardins, A.
    Vredenburgh, J. J.
    Rich, J. N.
    Gururangan, S.
    Friedman, A. H.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Phase I study of vorinostat combined with isotretinoin and temozolomide in adults with recurrent malignant gliomas.
    Penas-Prado, Marta
    Hess, Kenneth R.
    Levin, Victor A.
    De Groot, John Frederick
    Colman, Howard
    Groves, Morris D.
    Conrad, Charles A.
    Loghin, Monica Elena
    Hunter, Kathy
    Gilbert, Mark R.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
    Aoki, Tomokazu
    Arakawa, Yoshiki
    Ueba, Tetsuya
    Oda, Masashi
    Nishida, Namiko
    Akiyama, Yukinori
    Tsukahara, Tetsuya
    Mikuni, Nobuhiro
    Miyamoto, Susumu
    NEURO-ONCOLOGY, 2017, 19 : 6 - 6
  • [29] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
    Aoki, Tomokazu
    Arakawa, Yoshiki
    Ueba, Tetsuya
    Oda, Masashi
    Nishida, Namiko
    Akiyama, Yukinori
    Tsukahara, Tetsuya
    Iwasaki, Koichi
    Mikuni, Nobuhiro
    Miyamoto, Susumu
    NEURO-ONCOLOGY, 2019, 21 : 12 - 12
  • [30] A phase II study of first-line temozolomide and second-line PCV in recurrent/progressive malignant gliomas.
    Soffietti, R
    Costanza, A
    Laguzzi, E
    Nobile, M
    Rudà, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 125S - 125S
12345